Literature DB >> 32641999

Erratum: The antihelminthic drug niclosamide effectively inhibits the malignant phenotypes of uveal melanoma in vitro and in vivo: Erratum.

Jingfeng Zhou1, Bei Jin1, Yanli Jin1, Yizhi Liu1, Jingxuan Pan1.   

Abstract

[This corrects the article DOI: 10.7150/thno.17451.]. © The author(s).

Entities:  

Year:  2020        PMID: 32641999      PMCID: PMC7330861          DOI: 10.7150/thno.47923

Source DB:  PubMed          Journal:  Theranostics        ISSN: 1838-7640            Impact factor:   11.556


In our article 1, there were one misplaced image in Fig. 2C and Fig. 6B, respectively. The corrected version of Figure 2C and Figure 6B are provided here. In addition, the description of the whole section regarding all the supported grants originally stated in the acknowledgements in the initially published version of this article 1 is replaced with: The study was supported by grant (Grant 2015A030312014 to J. Pan) from Natural Science Foundation of Guangdong Province. The corrections made in this erratum do not affect the original conclusions. The authors apologize for any inconvenience or misunderstanding that these errors may have caused.
  1 in total

1.  The antihelminthic drug niclosamide effectively inhibits the malignant phenotypes of uveal melanoma in vitro and in vivo.

Authors:  Jingfeng Zhou; Bei Jin; Yanli Jin; Yizhi Liu; Jingxuan Pan
Journal:  Theranostics       Date:  2017-04-03       Impact factor: 11.556

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.